Literature DB >> 32118561

Clinical Guideline Highlights for the Hospitalist: The GOLD and NICE Guidelines for the Management of COPD.

Anna Neumeier1,2, Robert Keith1,3.   

Abstract

GUIDELINE TITLE: Chronic obstructive pulmonary disease in over 16s: Diagnosis and management1 RELEASE DATE: December 5, 2018 with update July 2019 PRIOR VERSION(S): NICE guideline CG101 June 2010, 2004 FUNDING SOURCE: Department of Health and Social Care, United Kingdom TARGET POPULATION: Patients age 16 and older with Chronic Obstructive Pulmonary Disease (COPD) GUIDELINE TITLE: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2019 Report)2 RELEASE DATE: November 14, 2018 PRIOR VERSION(S): 2017, 2016, 2015, 2014, 2013, 2008, 2001 FUNDING SOURCE: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) TARGET POPULATION: Adults with Chronic Obstructive Pulmonary Disease (COPD).

Entities:  

Mesh：

Year:  2020        PMID： 32118561     DOI： 10.12788/jhm.3368

Source DB:  PubMed          Journal:  J Hosp Med        ISSN： 1553-5592            Impact factor:   2.960


  9 in total

Review 1.  Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review.

Authors:  Antonella Laria; Alfredo Maria Lurati; Gaetano Zizzo; Eleonora Zaccara; Daniela Mazzocchi; Katia Angela Re; Mariagrazia Marrazza; Paola Faggioli; Antonino Mazzone
Journal:  Front Med (Lausanne)       Date:  2022-05-13

2.  A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease.

Authors:  Yahui Shen; Lina Wang; Yunhui Wu; Yingwei Ou; Huiyu Lu; Xin Yao
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

Review 3.  Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy.

Authors:  Przemyslaw Wielgat; Karol Rogowski; Katarzyna Niemirowicz-Laskowska; Halina Car
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

4.  Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A Prospective Pilot Study.

Authors:  Pin-Kuei Fu; Yu-Feng Wei; Chau-Chyun Sheu; Chen-Yu Wang; Chi-Kuei Hsu; Chia-Min Chen; Wei-Chih Chen; Kuang-Yao Yang
Journal:  Pharmaceutics       Date:  2020-12-31       Impact factor: 6.321

5.  Muscle weakness assessment in non-hypoxemic COPD out-patients at tertiary care hospitals.

Authors:  Faisal Faiyaz Zuberi; Bader Faiyaz Zuberi; Faiza Sadaqat Ali; Nimrah Bader
Journal:  Pak J Med Sci       Date:  2021 Mar-Apr       Impact factor: 1.088

6.  Use of bronchoscopic steam thermal ablation (BTVA) in a clinically compromised patient.

Authors:  Roberto Marchese; Chiara Lo Nigro; Federica Scaduto
Journal:  J Cardiothorac Surg       Date:  2022-02-07       Impact factor: 1.637

7.  Mapping the global research landscape and hotspot of exercise therapy and chronic obstructive pulmonary disease: A bibliometric study based on the web of science database from 2011 to 2020.

Authors:  Yu Zhou; Xiaodan Liu; Weibing Wu
Journal:  Front Physiol       Date:  2022-08-11       Impact factor: 4.755

8.  The Clinical Efficiency and the Mechanism of Sanzi Yangqin Decoction for Chronic Obstructive Pulmonary Disease.

Authors:  Mengqi Wang; Wenwen Gu; Fuguang Kui; Fan Gao; Yuji Niu; Wenwen Li; Yaru Zhang; Lijuan Guo; Shengnan Geng; Gangjun Du
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

9.  High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial.

Authors:  Dingyu Tan; Joseph Harold Walline; Bingyu Ling; Yan Xu; Jiayan Sun; Bingxia Wang; Xueqin Shan; Yunyun Wang; Peng Cao; Qingcheng Zhu; Ping Geng; Jun Xu
Journal:  Crit Care       Date:  2020-08-06       Impact factor: 9.097
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.